Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

colgate-palmolive co. - CL

CL

Close Chg Chg %
99.07 -1.80 -1.81%

Closed Market

97.28

-1.80 (1.81%)

Volume: 6.27M

Last Updated:

Mar 2, 2026, 3:59 PM EDT

Trade Now

Company Overview: colgate-palmolive co. - CL

CL Key Data

Open

$98.82

 Day Range

96.78 - 98.82

52 Week Range

74.55 - 100.18

 Market Cap

$79.47B

Shares Outstanding

801.55M

 Public Float

800.41M

Beta

0.27

 Rev. Per Employee

N/A

P/E Ratio

37.72

 EPS

$2.63

Yield

209.80%

 Dividend

$0.52

EX-DIVIDEND DATE

Jan 21, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

7.15M

  

CL Performance

1 Week
 
 4.26%
 
1 Month
 
 9.80%
 
3 Months
 
 26.99%
 
1 Year
 
 8.74%
 
5 Years
 
 30.34%
 

CL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 23
Full Ratings ➔

About colgate-palmolive co. - CL

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care, and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.

CL At a Glance

Colgate-Palmolive Co.
300 Park Avenue
New York, New York 10022-7499
Phone 1-212-310-2000 Revenue 20.38B
Industry Household/Personal Care Net Income 2.13B
Sector Consumer Non-Durables 2025 Sales Growth 1.398%
Fiscal Year-end 12 / 2026 Employees 33,600
View SEC Filings

CL Valuation

P/E Current 37.112
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 30.063
Price to Sales Ratio 3.145
Price to Book Ratio 1,172.40
Price to Cash Flow Ratio 15.27
Enterprise Value to EBITDA 14.59
Enterprise Value to Sales 3.511
Total Debt to Enterprise Value 0.12

CL Efficiency

Revenue/Employee 606,607.143
Income Per Employee 63,452.381
Receivables Turnover 12.168
Total Asset Turnover 1.259

CL Liquidity

Current Ratio 0.833
Quick Ratio 0.537
Cash Ratio 0.204

CL Profitability

Gross Margin 59.724
Operating Margin 20.974
Pretax Margin 15.008
Net Margin 10.46
Return on Assets 13.17
Return on Equity 1,603.008
Return on Total Capital 24.768
Return on Invested Capital 27.815

CL Capital Structure

Total Debt to Total Equity 15,840.741
Total Debt to Total Capital 99.373
Total Debt to Total Assets 52.382
Long-Term Debt to Equity 13,553.704
Long-Term Debt to Total Capital 85.026
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Colgate-palmolive Co. - CL

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
17.97B 19.46B 20.10B 20.38B
Sales Growth
+3.13% +8.29% +3.31% +1.40%
Cost of Goods Sold (COGS) incl D&A
7.82B 8.20B 8.00B 8.21B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
545.00M 567.00M 605.00M 630.00M
Depreciation
465.00M 495.00M 530.00M 552.00M
Amortization of Intangibles
80.00M 72.00M 75.00M 78.00M
COGS Growth
+9.67% +4.87% -2.48% +2.68%
Gross Income
10.15B 11.26B 12.11B 12.17B
Gross Income Growth
-1.39% +10.93% +7.52% +0.55%
Gross Profit Margin
+56.49% +57.87% +60.23% +59.72%
2022 2023 2024 2025 5-year trend
SG&A Expense
6.57B 7.12B 7.72B 7.90B
Research & Development
320.00M 343.00M 355.00M 366.00M
Other SG&A
6.25B 6.78B 7.37B 7.53B
SGA Growth
+2.47% +8.45% +8.47% +2.27%
Other Operating Expense
- - - -
-
Unusual Expense
830.00M 328.00M 85.00M 906.00M
EBIT after Unusual Expense
2.75B 3.81B 4.30B 3.37B
Non Operating Income/Expense
72.00M (132.00M) (50.00M) (43.00M)
Non-Operating Interest Income
14.00M 55.00M 67.00M 75.00M
Equity in Earnings of Affiliates
12.00M 17.00M 22.00M 20.00M
Interest Expense
167.00M 287.00M 292.00M 267.00M
Interest Expense Growth
+42.74% +71.86% +1.74% -8.56%
Gross Interest Expense
172.00M 299.00M 292.00M 267.00M
Interest Capitalized
- - 5.00M 12.00M
-
Pretax Income
2.66B 3.39B 3.96B 3.06B
Pretax Income Growth
-13.83% +27.52% +16.63% -22.67%
Pretax Margin
+14.80% +17.43% +19.68% +15.01%
Income Tax
693.00M 937.00M 907.00M 798.00M
Income Tax - Current - Domestic
199.00M 72.00M 188.00M 642.00M
Income Tax - Current - Foreign
- 494.00M 865.00M 719.00M
Income Tax - Deferred - Domestic
- - - 156.00M
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
12.00M 17.00M 22.00M 20.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
1.97B 2.46B 3.05B 2.26B
Minority Interest Expense
182.00M 155.00M 160.00M 129.00M
Net Income
1.78B 2.30B 2.89B 2.13B
Net Income Growth
-17.59% +28.85% +25.61% -26.20%
Net Margin Growth
+9.93% +11.82% +14.37% +10.46%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
1.78B 2.30B 2.89B 2.13B
Preferred Dividends
- - - -
-
Net Income Available to Common
1.78B 2.30B 2.89B 2.13B
EPS (Basic)
2.1342 2.7798 3.527 2.6363
EPS (Basic) Growth
-16.74% +30.25% +26.88% -25.25%
Basic Shares Outstanding
836.40M 827.40M 819.10M 808.70M
EPS (Diluted)
2.128 2.7738 3.5095 2.6285
EPS (Diluted) Growth
-16.66% +30.35% +26.52% -25.10%
Diluted Shares Outstanding
838.80M 829.20M 823.20M 811.10M
EBITDA
4.13B 4.71B 4.99B 4.91B
EBITDA Growth
-7.02% +13.95% +5.99% -1.66%
EBITDA Margin
+22.99% +24.19% +24.81% +24.07%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 97.222
Number of Ratings 23 Current Quarters Estimate 0.944
FY Report Date 03 / 2026 Current Year's Estimate 3.865
Last Quarter’s Earnings 0.95 Median PE on CY Estimate N/A
Year Ago Earnings 3.69 Next Fiscal Year Estimate 4.118
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 16 16 19 19
Mean Estimate 0.94 0.97 3.87 4.12
High Estimates 0.97 0.99 3.93 4.25
Low Estimate 0.91 0.92 3.69 3.85
Coefficient of Variance 1.89 1.66 1.34 2.03

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 11 11 10
OVERWEIGHT 1 1 2
HOLD 9 9 9
UNDERWEIGHT 2 2 0
SELL 0 0 1
MEAN Overweight Overweight Overweight

Insider Actions for Colgate-palmolive Co. - CL

Date Name Shares Transaction Value
Feb 26, 2026 John Hazlin Chief Growth Officer 24,422 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share 2,371,376.20
Feb 26, 2026 Jennifer M. Daniels CLO and Secretary 102,195 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Jennifer M. Daniels CLO and Secretary 89,844 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share 8,723,852.40
Feb 26, 2026 Panagiotis Tsourapas COO, Eur., APac, Afr Eur, Skin 34,710 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Panagiotis Tsourapas COO, Eur., APac, Afr Eur, Skin 21,629 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share 2,100,175.90
Feb 26, 2026 Noel R. Wallace Chairman, President & CEO; Director 430,173 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Noel R. Wallace Chairman, President & CEO; Director 361,921 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share 35,142,529.10
Feb 26, 2026 Gregory Malcolm EVP and Controller 18,158 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Gregory Malcolm EVP and Controller 15,898 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share 1,543,695.80
Feb 26, 2026 Stanley J. Sutula Chief Financial Officer 94,066 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Stanley J. Sutula Chief Financial Officer 74,320 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share 7,216,472.00
Feb 26, 2026 John Hazlin Chief Growth Officer 30,539 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Sally Massey Chief Human Resources Officer 30,590 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 26, 2026 Sally Massey Chief Human Resources Officer 22,384 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.1 per share 2,173,486.40
Feb 13, 2026 John Hazlin Chief Growth Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Apr 4, 2025 Brian O. Newman Director 2,597 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $91.99 per share 238,898.03
Apr 4, 2025 Lorrie M. Norrington Director 36,002 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $91.99 per share 3,311,823.98
Apr 4, 2025 John P. Bilbrey Director 33,688 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $91.99 per share 3,098,959.12

Colgate-Palmolive Co. in the News

ZipRecruiter IPO: 5 things to know

ZipRecruiter is taking its business to the next level and is Wall Street's newest public company ready to cash in on the tight job market.